Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the composition of drugs for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.